United States Hip Reconstruction Market Outlook to 2025 - Hip Resurfacing, Partial Hip Replacement and Others

1.1 List of Tables
1.2 List of Figures

2.1 What Is This Report About?
2.2 Hip Reconstruction Segmentation
2.3 Definitions of Markets Covered in the Report

3.1 Hip Reconstruction Market, United States, Revenue ($m), 2015-2025
3.1.1 Partial Hip Replacement Market, United States, Revenue ($m), by Segment, 2015-2025
3.1.2 Primary Hip Replacement Market, United States, Revenue ($m), by Segment, 2015-2025
3.2 Hip Reconstruction Market, United States, Volume (Units), 2015-2025
3.2.1 Partial Hip Replacement Market, United States, Volume (Units), by Segment, 2015-2025
3.2.2 Primary Hip Replacement Market, United States, Volume (Units), by Segment, 2015-2025
3.3 Hip Reconstruction Market, United States, Average Price ($) , 2015-2025
3.4 Hip Reconstruction Market, United States, Distribution Share by Revenue ($m), 2019
3.5 Hip Reconstruction Market, United States, Company Share by Revenue ($m), 2019

4.1 Zimmer Biomet Holdings Inc
4.1.1 Company Overview
4.2 Stryker Corp
4.2.1 Company Overview
4.3 DePuy Synthes Inc
4.3.1 Company Overview
4.4 Smith & Nephew Plc
4.4.1 Company Overview
4.5 MicroPort Scientific Corp
4.5.1 Company Overview
4.6 Exactech Inc
4.6.1 Company Overview
4.7 Medacta Group SA
4.7.1 Company Overview

6.1 Debt Offerings
6.1.1 Stryker Prices USD600 Million in Public Offering of 0.600% Senior Notes Due 2023
6.1.2 Stryker Raises USD650 Million in Public Offering of 1.15% Notes Due 2025
6.1.3 Stryker Raises USD1 Billion in Public Offering of 1.95% Notes Due 2030
6.1.4 Stryker Raises USD650 Million in Public Offering of 2.9% Notes Due 2050
6.1.5 Zimmer Biomet Prices Public Offering of 3.55% Notes Due 2030 for USD900 Million
6.1.6 Zimmer Biomet Prices Public Offering of 3.05% Notes Due 2026 for USD600 Million
6.2 Equity Offerings
6.2.1 SINTX Technologies Plans to Raise up to USD75 Million in Public Offering of Securities
6.2.2 SINTX Technologies to Raise USD8.19 Million in Public Offering of Shares
6.2.3 SINTX Technologies Prices Private Placement of Shares for USD3 Million
6.2.4 SINTX Technologies to Raise USD41.3 Million in Public offering of Shares
6.2.5 SINTX Technologies Prices Private Placement of Shares for USD5.6 Million
6.2.6 Sintx Technologies to Raise USD8.8 million in Rights Offering

7.1 Corporate Communications
7.1.1 Mar 05, 2020: Ovid Therapeutics announces presentations on OV935/TAK935 (soticlestat) at the American Academy of Neurology 2020 Annual Meeting
7.1.2 Mar 02, 2020: Stryker announces new Investor Relations leader
7.1.3 Feb 25, 2020: Stryker announces nomination of new Director, Lisa Skeete Tatum
7.1.4 Feb 06, 2020: Henry Ford Health System announces new president and CEO Of Health Alliance Plan
7.1.5 Feb 04, 2020: Henry Ford Medical Group names new Chair of Board of Governors
7.1.6 Jan 25, 2020: Siemens Healthineers India launches ACUSON Redwood Ultrasound System at IRIA 2020
7.1.7 Jan 22, 2020: Amiri Hospital in Kuwait goes lives with Agfa HealthCare’s Enterprise Imaging for Radiology
7.1.8 Jan 08, 2020: Zimmer Biomet appoints Keri P. Mattox as Senior Vice President of Investor Relations and Chief Communications Officer
7.1.9 Jan 06, 2020: Exactech announces leadership transition
7.2 Financial Announcements
7.2.1 Feb 04, 2020: Zimmer Biomet announces fourth quarter and full-year 2019 financial results
7.2.2 Jan 28, 2020: Stryker reports 2019 results and 2020 outlook
7.3 Government and Public Interest
7.3.1 Jun 30, 2020: HSS study identifies RA patients with worse outcomes after hip or knee replacement
7.4 Other Significant Developments
7.4.1 Sep 16, 2020: Willamette Surgery Center now offering highly advanced robotic-arm assisted joint replacement procedures with Stryker's mako system
7.4.2 Jun 29, 2020: DePuy Synthes renews cooperation agreement with AO Foundation to continue advancement of surgical education
7.4.3 May 28, 2020: Conformis announces settlement of patent dispute
7.5 Product News
7.5.1 Jun 08, 2020: No difference in outcomes between anterior and posterior surgical approaches for outpatient total hip replacement
7.6 Strategy And Business Planning
7.6.1 Feb 20, 2020: Galderma announces New England Journal of Medicine publication from phase 2 study of investigational therapy Nemolizumab in patients with moderate to severe Prurigo Nodularis
7.6.2 Jan 23, 2020: Brainlab acquires San Diego-based VisionTree Software
7.6.3 Jan 16, 2020: New Bloomfield Township Medical Center: Enhancing the care experience

8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 Consulting
8.3 Contact
8.4 Disclaimer

Table 1: Hip Reconstruction Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 2: Hip Reconstruction Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 3: Partial Hip Replacement Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 4: Partial Hip Replacement Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 5: Primary Hip Replacement Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 6: Primary Hip Replacement Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 7: Hip Reconstruction Market, United States, Volume (Units), 2015-2020
Table 8: Hip Reconstruction Market, United States, Volume (Units), 2021-2025
Table 9: Partial Hip Replacement Market, United States, Volume (Units), 2015-2020
Table 10: Partial Hip Replacement Market, United States, Volume (Units), 2021-2025
Table 11: Primary Hip Replacement Market, United States, Volume (Units), 2015-2020
Table 12: Primary Hip Replacement Market, United States, Volume (Units), 2021-2025
Table 13: Hip Reconstruction Market, United States, Average Price ($), 2015-2020
Table 14: Hip Reconstruction Market, United States, Average Price ($), 2021-2025
Table 15: Hip Reconstruction Market, United States, Distribution Share by Revenue ($m), USD Constant, 2019
Table 16: Hip Reconstruction Market, United States, Company Share by Revenue ($m), USD Constant, 2019
Table 17: Hip Reconstruction Market Pipeline Products
Table 18: Stryker Prices USD600 Million in Public Offering of 0.600% Senior Notes Due 2023
Table 19: Stryker Raises USD650 Million in Public Offering of 1.15% Notes Due 2025
Table 20: Stryker Raises USD1 Billion in Public Offering of 1.95% Notes Due 2030
Table 21: Stryker Raises USD650 Million in Public Offering of 2.9% Notes Due 2050
Table 22: Zimmer Biomet Prices Public Offering of 3.55% Notes Due 2030 for USD900 Million
Table 23: Zimmer Biomet Prices Public Offering of 3.05% Notes Due 2026 for USD600 Million
Table 24: SINTX Technologies Plans to Raise up to USD75 Million in Public Offering of Securities
Table 25: SINTX Technologies to Raise USD8.19 Million in Public Offering of Shares
Table 26: SINTX Technologies Prices Private Placement of Shares for USD3 Million
Table 27: SINTX Technologies to Raise USD41.3 Million in Public offering of Shares
Table 28: SINTX Technologies Prices Private Placement of Shares for USD5.6 Million
Table 29: Sintx Technologies to Raise USD8.8 million in Rights Offering
Table 30: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country

Figure 1: Hip Reconstruction Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 2: Partial Hip Replacement Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 3: Primary Hip Replacement Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 4: Hip Reconstruction Market, United States, Volume (Units), 2015-2025
Figure 5: Partial Hip Replacement Market, United States, Volume (Units), 2015-2025
Figure 6: Primary Hip Replacement Market, United States, Volume (Units), 2015-2025
Figure 7: Hip Reconstruction Market, United States, Company Share (%) 2019